| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| STAAR SURGICAL CO | CFO | Common Stock | 8,586 | $154,548 | $18.00 | 17 Mar 2025 | Direct |
| Lineage Cell Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 75,000 | 01 Jul 2025 | Direct | ||
| STAAR SURGICAL CO | CFO | Restricted Stock Units | 41,867 | 25 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2025 | 1 | $0 | 4 | Director | 02 Jul 2025, 21:00 |
| STAA | STAAR SURGICAL CO | 25 Jun 2025 | 1 | $0 | 4 | CFO | 26 Jun 2025, 18:31 |
| STAA | STAAR SURGICAL CO | 17 Mar 2025 | 0 | $0 | 3 | Interim CFO | 18 Mar 2025, 18:02 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2024 | 1 | $0 | 4 | Director | 03 Jul 2024, 17:00 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2023 | 1 | $0 | 4 | Director | 03 Jul 2023, 17:46 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 06 Jul 2022, 16:15 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 01 Jul 2021, 18:29 |
| LCTX | Lineage Cell Therapeutics, Inc. | 29 Jun 2021 | 3 | -$1,702 | 4 | Director | 30 Jun 2021, 19:01 |